Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 2
2017 5
2018 1
2019 2
2020 3
2021 5
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
On naivety of T cells in inflammatory bowel disease: a review.
Smids C, Horjus Talabur Horje CS, Wahab PJ, Groenen MJ, Middendorp S, van Lochem EG. Smids C, et al. Among authors: horjus talabur horje cs. Inflamm Bowel Dis. 2015 Jan;21(1):167-72. doi: 10.1097/MIB.0000000000000221. Inflamm Bowel Dis. 2015. PMID: 25268637 Review.
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease.
Mahmoud R, Savelkoul EHJ, Mares W, Goetgebuer R, Witteman BJM, de Koning DB, van Tuyl SAC, Minderhoud I, Lutgens MWMD, Akol-Simsek D, van Schaik FDM, Fidder HH, Jansen JM, van Boeckel PGA, Mahmmod N, Horjus-Talabur Horje CS, Römkens TEH, Colombel JF, Hoentjen F, Jharap B, Oldenburg B; Dutch Initiative on Crohn’s and Colitis (ICC) and the AWARE study group. Mahmoud R, et al. Among authors: horjus talabur horje cs. Clin Gastroenterol Hepatol. 2023 Mar;21(3):750-760.e4. doi: 10.1016/j.cgh.2022.08.024. Epub 2022 Aug 31. Clin Gastroenterol Hepatol. 2023. PMID: 36055567 Free article.
Analysis of Intestinal T-Cell Subsets in Inflammatory Bowel Disease.
Roosenboom B, van Lochem EG, Smids C, Groenen MJM, Wahab PJ, Horjus Talabur Horje CS. Roosenboom B, et al. Among authors: horjus talabur horje cs. Inflamm Bowel Dis. 2020 Jan 6;26(2):e13. doi: 10.1093/ibd/izz310. Inflamm Bowel Dis. 2020. PMID: 31904085 No abstract available.
Integrin αEβ7 in Inflammatory Bowel Disease: Friend or Foe?
Smids C, Horjus-Talabur Horje CS, van Lochem EG. Smids C, et al. Among authors: horjus talabur horje cs. Gastroenterology. 2016 Jul;151(1):213-4. doi: 10.1053/j.gastro.2016.02.084. Epub 2016 May 28. Gastroenterology. 2016. PMID: 27243635 No abstract available.
Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients.
Brand EC, Klaassen MAY, Gacesa R, Vich Vila A, Ghosh H, de Zoete MR, Boomsma DI, Hoentjen F, Horjus Talabur Horje CS, van de Meeberg PC, Willemsen G, Fu J, Wijmenga C, van Wijk F, Zhernakova A, Oldenburg B, Weersma RK; Dutch TWIN-IBD consortium and the Dutch Initiative on Crohn and Colitis. Brand EC, et al. Among authors: horjus talabur horje cs. Gastroenterology. 2021 May;160(6):1970-1985. doi: 10.1053/j.gastro.2021.01.030. Epub 2021 Jan 19. Gastroenterology. 2021. PMID: 33476671 Free article.
25 results